Seeking to Free Itself from Filing Fees, Lion Bioscience Asks SEC to Terminate Registration | GenomeWeb

NEW YORK, May 19 (GenomeWeb News) - Hoping to save more money, Lion Bioscience today filed a request with the SEC to terminate the registration of the company's ordinary shares with the agency, Lion said in a statement.


Lion said it expects this termination to become effective 90 days after its filing with the SEC. The filing frees the company from the obligation to file annual reports and other forms with the agency, Lion added.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.